Cytokinetics (CYTK) Short term Debt (2016 - 2024)
Historic Short term Debt for Cytokinetics (CYTK) over the last 12 years, with Q3 2024 value amounting to $12.5 million.
- Cytokinetics' Short term Debt changed N/A to $12.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $12.5 million, marking a year-over-year change of. This contributed to the annual value of $10.1 million for FY2023, which is 95219.21% up from last year.
- As of Q3 2024, Cytokinetics' Short term Debt stood at $12.5 million.
- In the past 5 years, Cytokinetics' Short term Debt registered a high of $16.9 million during Q3 2021, and its lowest value of $958000.0 during Q4 2022.
- In the last 4 years, Cytokinetics' Short term Debt had a median value of $11.4 million in 2021 and averaged $10.3 million.
- Over the last 5 years, Cytokinetics' Short term Debt had its largest YoY gain of 95219.21% in 2023, and its largest YoY loss of 95219.21% in 2023.
- Quarter analysis of 4 years shows Cytokinetics' Short term Debt stood at $16.9 million in 2021, then tumbled by 94.32% to $958000.0 in 2022, then skyrocketed by 952.19% to $10.1 million in 2023, then rose by 24.01% to $12.5 million in 2024.
- Its Short term Debt was $12.5 million in Q3 2024, compared to $13.2 million in Q2 2024 and $11.5 million in Q1 2024.